Supriya Peshan, a second-year IM resident physician at Northern Community Hospital in conversation with Dr. Cathy Eng from the Vanderbilt Ingram Cancer Center
Dr. Eng shared her expertise on the FRESCO2 study, the integration of Fruquintinib into current treatment regimens, and the significance of circulating tumor DNA. We also explore the benefits of attending oncology conferences, both in-person and virtually, for residents, fellows, and community oncologists.
